Modification of the 8^th AJCC staging system of pancreatic ductal adenocarcinoma

Teddy Sutardji Nagaria¹, Huamin Wang^{1

2}

Affiliations

¹ Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Editorial

Teddy Sutardji Nagaria et al. Hepatobiliary Surg Nutr. 2020 Feb.

. 2020 Feb;9(1):95-97.

doi: 10.21037/hbsn.2019.08.01.

Teddy Sutardji Nagaria¹, Huamin Wang^{1

2}

¹ Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
Shi S, Hua J, Liang C, Meng Q, Liang D, Xu J, Ni Q, Yu X. Shi S, et al. Ann Surg. 2019 May;269(5):944-950. doi: 10.1097/SLA.0000000000002668. Ann Surg. 2019. PMID: 29334560

1. Allen PJ, Kuk D, Castillo CF, et al. Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg 2017;265:185-91. - PMC - PubMed
1. Saka B, Balci S, Basturk O, et al. Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol (7th edition) inapplicable and insignificant: a size-based staging system (pT1: ≤2, pT2: >2–≤4, pT3: >4 cm) is more valid and clinically relevant. Ann Surg Oncol 2016;23:2010-8. - PMC - PubMed
1. Shi S, Hua J, Liang C, et al. Proposed modification of the 8th edition of the AJCC staging system for pancreatic ductal adenocarcinoma. Ann Surg 2019;269:944-50. - PubMed
1. Huebner M, Kendrick M, Reid-Lombardo KM, et al. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg 2012;16:920-6. 10.1007/s11605-012-1853-2 - DOI - PubMed
1. Vuarnesson H, Lupinacci RM, Semoun O, et al. Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. Eur J Surg Oncol 2013;39:1116-21. 10.1016/j.ejso.2013.07.089 - DOI - PubMed